Litigation Details for Plaintiff(s) v. Defendant(s) (D. Del. 2019)

Plaintiff(s) v. Defendant(s) (D. Del. 2019)

Docket		Date Filed	2019-12-31
Court	District Court, D. Delaware	Date Terminated
Cause	99:9999 (Miscellaneous Case - Cause Not Known)	Assigned To
Jury Demand	None	Referred To
Parties	DEFENDANT(S); PLAINTIFF(S)
Patents	10,004,717; 10,010,507; 10,052,267; 10,124,000; 10,143,723; 10,143,792; 10,172,808; 10,188,632; 10,206,939; 10,307,419; 10,426,780; 10,478,453; 10,543,192; 10,548,875; 10,583,155; 10,617,698; 7,056,500; 7,229,636; 7,314,938; 7,404,489; 7,442,830; 7,514,444; 7,691,411; 7,723,390; 7,741,356; 7,745,460; 7,790,743; 7,846,961; 7,879,349; 7,888,362; 7,928,122; 8,003,111; 8,003,353; 8,008,006; 8,039,009; 8,084,047; 8,133,893; 8,158,616; 8,168,655; 8,349,840; 8,367,701; 8,420,629; 8,476,008; 8,476,284; 8,497,277; 8,592,450; 8,618,109; 8,618,160; 8,697,711; 8,735,403; 8,754,091; 8,859,504; 8,859,610; 8,927,574; 8,940,714; 8,952,015; 8,957,079; 9,073,933; 9,079,949; 9,085,553; 9,161,926; 9,175,017; 9,181,257; 9,216,174; 9,242,986; 9,259,414; 9,353,088; 9,415,007; 9,447,077; 9,517,219; 9,522,919; 9,527,833; 9,675,587; 9,744,105; 9,763,933; 9,775,808; 9,839,637; 9,889,144; 9,890,141; 9,937,181; 9,957,232; RE41,783; RE46,284
Attorneys	Plaintiff(s)
Link to Docket	External link to docket

Biologic Drugs cited in Plaintiff(s) v. Defendant(s)

Details for Plaintiff(s) v. Defendant(s) (D. Del. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-09-25	1071	Complaint	,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). {01611126;v1 } …the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 18. The United States Patent and Trademark Office (	External link to document
2020-09-25	1072	Complaint	9,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). 33. In response to Lupin…the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 25. The United States Patent and Trademark Office (	External link to document
2020-09-25	1073	Complaint	9,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). {01611225;v1 } …the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 36. The United States Patent and Trademark Office (	External link to document
2020-10-07	1131	Complaint	United States Patent Nos. 10,617,698 (“the ’698 Patent”), 10,660,908 (“the ’908 Patent”), 10,682,364…10,682,364 (“the ’364 Patent”), 10,688,108 (“the ’108 Patent”), and 10,716,799 (“the ’799 Patent”) (collectively… This is a civil action for patent infringement arising under the patent laws of the United States, … This is a civil action for patent infringement arising under the patent laws of the United States, …are covered by claims of the Patents-in-Suit. 22. The Patents-in-Suit are listed in Approved	External link to document
2020-10-08	1133	Complaint	9,763,886 (“the ‘886 patent”); 9,073,933 (“the ’933 patent”); 9,522,919 (“the ’919 patent”); and 10,407,434…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 9,073,933) 58. Purdue…United States Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,775,808 (“the ’808 patent”); 9,763,886…infringed the ’886 patent. Defendants have infringed the Orange Book patents and the ’886 patent at least under…1. This is an action for patent infringement arising under the patent laws of the United States,	External link to document
2020-10-09	1140	Complaint	Pharmaceuticals Limited’s Dapsone Gel, 7.5%; U.S. Patent Nos. 9,161,926 and 9,517,219” (the “Notice Letter”). …This is an action for patent infringement brought under the United States Patent Act and the Hatch-Waxman…the expiration of United States Patent No. 9,517,219 (“the ’219 Patent”), which covers, inter alia, the… THE PATENT-IN-SUIT 16. On December 13, 2016, the United States Patent and Trademark…before the ʼ219 Patent expires. CLAIM FOR INFRINGEMENT OF THE ’219 PATENT 28.	External link to document
2018-09-21	1168		prior to the expiration of U.S. Patent No. 9,957,232 (the “’232 patent”). As set forth in its… The ’232 Patent 25. U.S. Patent No. 9,957,232, entitled “… 1. This is an action for patent infringement under the patent laws of the United States, Title…forth in greater detail in the ’232 patent, the claims of the ’232 patent, incorporated by reference herein…the ’232 patent. 31. Apotex had knowledge of the claims of the ’232 patent before	External link to document